Rationale and Design of the CANONICAL Study　― Randomized, Open-Label Study to Evaluate the Efficacy and Safety of Canagliflozin for Heart Failure With Preserved Ejection Fraction With Type 2 Diabetes Mellitus ―

Background: Sodium-glucose cotransporter 2 inhibitors (SGLT2-I) have beneficial cardiovascular effects, including reduction in hospitalization for heart failure (HF). The aim of this study is to explore the efficacy and safety of canagliflozin compared with standard diabetes treatment in elderly pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Kasama, Shu, Masuyama, Tohru, Uemura, Shiro, Sato, Yukihito, Hiramitsu, Shinya, Masuda, Izuru, Yamamoto, Kazuhiro, Komatsu, Sei, Anzai, Toshihisa, Nishimura, Kunihiro, Ueda, Tomoya, Kasahara, Masato, Tanaka, Hiroyuki, Susuta, Yutaka, Saito, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Circulation Society 2019
Materias:
Protocol Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892479/
https://www.ncbi.nlm.nih.gov/pubmed/33693161
http://dx.doi.org/10.1253/circrep.CR-19-0049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7892479/
https://www.ncbi.nlm.nih.gov/pubmed/33693161
http://dx.doi.org/10.1253/circrep.CR-19-0049

Ejemplares similares